Literature DB >> 7491012

Day-time naps and melatonin in blind people.

S Lockley, H Tabandeh, D Skene, R Buttery, A Bird, R Defrace, J Arendt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7491012     DOI： 10.1016/s0140-6736(95)92508-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Light, blindness and endocrine secretions.

Authors:  A Bellastella; G Amato; A Bizzaro; C Carella; T Criscuolo; S Iorio; V I Muccitelli; G Pisano; A A Sinisi; A De Bellis
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

Review 2.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Circadian-related sleep disorders and sleep medication use in the New Zealand blind population: an observational prevalence survey.

Authors:  Guy R Warman; Matthew D M Pawley; Catherine Bolton; James F Cheeseman; Antonio T Fernando; Josephine Arendt; Anna Wirz-Justice
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

Review 4.  Visual impairment and circadian rhythm disorders.

Authors:  Steven W Lockley; Josephine Arendt; Debra J Skene
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

5.  Long-Term Single and Joint Effects of Excessive Daytime Napping on the HOMA-IR Index and Glycosylated Hemoglobin: A Prospective Cohort Study.

Authors:  Xue Li; Xiuyu Pang; Qiao Zhang; Qiannuo Qu; Zhigang Hou; Zhipeng Liu; Lin Lv; Guanqiong Na; Wei Zhang; Changhao Sun; Ying Li
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.